Abstract
Full text available.
Current Drug Targets
Title:Concluding Notes of Special Issue “α-7 Nicotinic Receptor (α7-nAChR): One Target Different Diseases”
Volume: 13 Issue: 5
Author(s): Patrizia Russo, Alfredo Cesario, Massimo Fini
Affiliation:
Abstract: Full text available.
Export Options
About this article
Cite this article as:
Patrizia Russo, Alfredo Cesario, Massimo Fini , Concluding Notes of Special Issue “α-7 Nicotinic Receptor (α7-nAChR): One Target Different Diseases” , Current Drug Targets 2012; 13 (5) . https://dx.doi.org/10.2174/138945012800398892
DOI https://dx.doi.org/10.2174/138945012800398892 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Alzheimer’s Disease Drugs- In Vitro Comparison of Cholinesterase Inhibition and beta-amyloid Modulation
Letters in Drug Design & Discovery The Potential Clinical Properties of Magnesium
Current Medicinal Chemistry Astrocytic 5-HT2B Receptor as in vitro and in vivo Target of SSRIs
Recent Patents on CNS Drug Discovery (Discontinued) 5HT1F- and 5HT7-Receptor Agonists for the Treatment of Migraines
CNS & Neurological Disorders - Drug Targets Protein Z and Ischemic Stroke
Vascular Disease Prevention (Discontinued) Fruitless Wolfberry-Sprout Extract Rescued Cognitive Deficits and Attenuated Neuropathology in Alzheimer’s Disease Transgenic Mice
Current Alzheimer Research Influence of Primary Auditory Cortex in the Characterization of Autism Spectrum in Young Adults using Brain Connectivity Parameters and Deep Belief Networks: An fMRI Study
Current Medical Imaging Clinically Relevant Genetic Variations in Drug Metabolizing Enzymes
Current Drug Metabolism Environmental Enrichment as a Positive Behavioral Intervention Across the Lifespan
Current Neuropharmacology Hepatocyte Growth Factor (HGF): Neurotrophic Functions and Therapeutic Implications for Neuronal Injury/Diseases
Current Signal Transduction Therapy Anticancer Drug Discovery using Chemical Genomics
Current Medicinal Chemistry Transcranial Direct Current Stimulation for the Treatment of Refractory Symptoms of Schizophrenia. Current Evidence and Future Directions
Current Pharmaceutical Design Cancer Pharmacogenomics: Germline DNA, Tumor DNA, or Both?
Current Pharmacogenomics In vitro Generated Mesenchymal Stem Cells: Suitable Tools to Target Insulin Dependent Diabetes Mellitus?
Current Stem Cell Research & Therapy Choline Nutrition Programs Brain Development Via DNA and Histone Methylation
Central Nervous System Agents in Medicinal Chemistry Calcium Salts Bone Regeneration Scaffolds: A Review Article
Current Stem Cell Research & Therapy The Soluble CTLA-4 Receptor and its Emerging Role in Autoimmune Diseases
Current Immunology Reviews (Discontinued) The Association of <i>CYP2D6*4</i> and <i>POR*28</i> Polymorphisms on Mirtazapine Plasma Level in Subjects with Major Depressive Disorder and Anxiety Disorders
Combinatorial Chemistry & High Throughput Screening Regional Cerebral Blood Flow and Cerebrovascular Reactivity in Alzheimer’s Disease and Vascular Dementia Assessed by Arterial Spinlabeling Magnetic Resonance Imaging
Current Neurovascular Research Brivaracetam Prevents the Over-expression of Synaptic Vesicle Protein 2A and Rescues the Deficits of Hippocampal Long-term Potentiation In Vivo in Chronic Temporal Lobe Epilepsy Rats
Current Neurovascular Research